Skip to main content
SpringerLink
Log in

Gastric Cancer

  • Chapter
  • First Online:
Surgical Oncology

  • 3559 Accesses

Abstract

Gastric cancer remains a global health problem. Delayed diagnosis compounded by nutritional decline associated both with the disease and the treatment often complicates its management. While surgical resection has remained the mainstay of treatment, adjuvant and neoadjuvant therapy incorporating radiation and chemotherapy have now become standard with data lending support to a multimodal therapeutic approach. This chapter highlights the clinical presentation, staging, extent of surgery required, and perioperative approaches to optimize outcomes in gastric cancer. Nuances inherent to global geographical variations in management are also discussed. Better understanding of the molecular biology of this disease may help identify additional targets for intervention and prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Karpeh M, Kelsen D, Tepper J. Cancer of the stomach. In: DeVita JV, Hellman S, Rosenberg S, editors. Cancer: principles & practice of oncology, vol. 1. 6th ed. Philadelphia: Lippincott-Williams-Wilkin; 2001. p. 1092–126.

    Google Scholar 

  2. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64: 31–49.

    PubMed  CAS  Google Scholar 

  3. Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001;20(12):1525–8.

    Article  PubMed  CAS  Google Scholar 

  4. Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000; 26(1):16–7.

    Article  PubMed  CAS  Google Scholar 

  5. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325(16):1127–31.

    Article  PubMed  CAS  Google Scholar 

  6. Tanner M, Hollmén M, Junttila TT, et al. Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol. 2005;16(2):273–8.

    Article  PubMed  CAS  Google Scholar 

  7. Yan B, Yau EX, Bte Omar SS, et al. A study of HER2 gene amplification and protein expression in gastric cancer. J Clin Pathol. 2010;63(9):839–42.

    Article  PubMed  Google Scholar 

  8. Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11(5): 531–46.

    PubMed  CAS  Google Scholar 

  9. Polkowski M, Palucki J, Wronska E, Szawlowski A, Nasierowska-Guttmejer A, Butruk E. Endosonography versus helical computed tomography for locoregional staging of gastric cancer. Endoscopy. 2004;36(7): 617–23.

    Article  PubMed  CAS  Google Scholar 

  10. Smyth E, Schoder H, Strong VE, et al. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer. 2012;118(22):5481–8.

    Article  PubMed  Google Scholar 

  11. Yamada A, Oguchi K, Fukushima M, Imai Y, Kadoya M. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. Ann Nucl Med. 2006;20(9):597–604.

    Article  PubMed  CAS  Google Scholar 

  12. Ilson DH, Minsky BD, Ku GY, et al. Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer. Cancer. 2012;118(11): 2820–7.

    Article  PubMed  CAS  Google Scholar 

  13. Leake PA, Cardoso R, Seevaratnam R, et al. A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer. Gastric Cancer. 2012;15 Suppl 1:S38–47.

    Article  PubMed  Google Scholar 

  14. Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol. 2005;12(5):347–53.

    Article  PubMed  Google Scholar 

  15. Siewert JR, Hölscher AH, Becker K, Gössner W. Cardia cancer: attempt at a therapeutically relevant classification. Chirurg. 1987;58(1):25–32.

    PubMed  CAS  Google Scholar 

  16. Compton C, Byrd D, Garcia-Aguilar J, et al. Stomach. In: Compton C, Byrd D, Garcia-Aguilar J, Kurtzman S, Olawaiye A, Washington M, editors. AJCC cancer staging atlas. 2nd ed. New York: Springer; 2012. p. 143–53.

    Chapter  Google Scholar 

  17. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg. 1981;11(2):127–39.

    Article  PubMed  CAS  Google Scholar 

  18. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12): 3077–9.

    Article  PubMed  Google Scholar 

  19. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg. 1987;11(4):418–25.

    Article  PubMed  CAS  Google Scholar 

  20. Yamao T, Shirao K, Ono H, et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer. 1996;77(4):602–6.

    Article  PubMed  CAS  Google Scholar 

  21. Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3(4):219–25.

    Article  PubMed  Google Scholar 

  22. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg. 1999;230(2):170–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  23. Gouzi JL, Huguier M, Fagniez PL, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg. 1989;209(2):162–6.

    Google Scholar 

  24. Hasler WL. Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol. 2011;8(8):438–53.

    Article  PubMed  CAS  Google Scholar 

  25. Kim HJ, Karpeh MS. Surgical approaches and outcomes in the treatment of gastric cancer. Semin Radiat Oncol. 2002;12(2):162–9.

    Article  PubMed  Google Scholar 

  26. Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004; 22(11):2069–77.

    Article  PubMed  CAS  Google Scholar 

  27. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.

    Article  PubMed  CAS  Google Scholar 

  28. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340(12):908–14.

    Article  PubMed  CAS  Google Scholar 

  29. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5): 439–49.

    Article  PubMed  Google Scholar 

  30. Jiang L, Yang KH, Guan QL, Zhao P, Chen Y, Tian JH. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis. J Surg Oncol. 2013;107(8):807–14.

    Article  PubMed  Google Scholar 

  31. Adachi Y, Suematsu T, Shiraishi N, et al. Quality of life after laparoscopy-assisted Billroth I gastrectomy. Ann Surg. 1999;229(1):49–54.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  32. Adachi Y, Shiraishi N, Shiromizu A, Bandoh T, Aramaki M, Kitano S. Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy. Arch Surg. 2000;135(7):806–10.

    Article  PubMed  CAS  Google Scholar 

  33. Goh PM, Alponat A, Mak K, Kum CK. Early international results of laparoscopic gastrectomies. Surg Endosc. 1997;11(6):650–2.

    Article  PubMed  CAS  Google Scholar 

  34. Xiong JJ, Nunes QM, Huang W, et al. Laparoscopic vs open total gastrectomy for gastric cancer: a meta-analysis. World J Gastroenterol. 2013;19(44):8114–32.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Huscher CG, Mingoli A, Sgarzini G, et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg. 2005;241(2):232–7.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Fujii K, Sonoda K, Izumi K, Shiraishi N, Adachi Y, Kitano S. T lymphocyte subsets and Th1/Th2 balance after laparoscopy-assisted distal gastrectomy. Surg Endosc. 2003;17(9):1440–4.

    Article  PubMed  CAS  Google Scholar 

  37. Hayashi H, Ochiai T, Shimada H, Gunji Y. Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer. Surg Endosc. 2005; 19(9):1172–6.

    Article  PubMed  CAS  Google Scholar 

  38. Lee JH, Han HS. A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results. Surg Endosc. 2005;19(2):168–73.

    Article  PubMed  Google Scholar 

  39. Kim YW, Baik YH, Yun YH, et al. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg. 2008;248(5): 721–7.

    Article  PubMed  Google Scholar 

  40. Kim HH, Hyung WJ, Cho GS, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report–a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg. 2010;251(3):417–20.

    Article  PubMed  Google Scholar 

  41. Kitano S, Shiraishi N, Uyama I, Sugihara K, Tanigawa N, Group JLSS. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg. 2007;245(1):68–72.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Song J, Lee HJ, Cho GS, et al. Recurrence following laparoscopy-assisted gastrectomy for gastric cancer: a multicenter retrospective analysis of 1,417 patients. Ann Surg Oncol. 2010;17(7):1777–86.

    Article  PubMed  Google Scholar 

  43. Hwang SH, Park DJ, Jee YS, et al. Actual 3-year survival after laparoscopy-assisted gastrectomy for gastric cancer. Arch Surg. 2009;144(6):559–64.

    Article  PubMed  Google Scholar 

  44. Pak KH, Hyung WJ, Son T, et al. Long-term oncologic outcomes of 714 consecutive laparoscopic gastrectomies for gastric cancer: results from the 7-year experience of a single institute. Surg Endosc. 2012; 26(1):130–6.

    Article  PubMed  Google Scholar 

  45. Schwarz RE, Zagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol. 2002;9(4):394–400.

    Article  PubMed  Google Scholar 

  46. Roviello F, Marrelli D, de Manzoni G, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg. 2003;90(9): 1113–9.

    Article  PubMed  CAS  Google Scholar 

  47. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21(19):3647–50.

    Article  PubMed  Google Scholar 

  48. Marrelli D, Roviello F. Prognostic score in gastric cancer patients. Ann Surg Oncol. 2007;14(2):362–4.

    Article  PubMed  Google Scholar 

  49. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10): 725–30.

    Article  PubMed  CAS  Google Scholar 

  50. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.

    Article  PubMed  CAS  Google Scholar 

  51. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18): 1810–20.

    Article  PubMed  CAS  Google Scholar 

  52. Schuhmacher C, Gretschel S, Lordick F, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol. 2010;28(35):5210–8.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Fuchs C, Tepper J, Niedzwiecki D, et al. Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: intergroup trial CALGB 80101. J Clin Oncol. 2011;29(256s):Abstr 4003.

    Google Scholar 

  54. Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715–21.

    Article  PubMed  CAS  Google Scholar 

  55. Lee J, Lim DH, Kim S, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol. 2012; 30(3):268–73.

    Article  PubMed  CAS  Google Scholar 

  56. Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315–21.

    Article  PubMed  CAS  Google Scholar 

  57. Noh S, Park S, Yang H, Chung H, Chung I, et al. Adjuvant capecitabine and oxaliplatin (Xelox) for gastric cancer after D2 gastrectomy: final results from the CLASSIC trial. Ann Oncol. 2013;24 Suppl 4:iv14.

    Article  Google Scholar 

  58. Smalley SR, Benedetti JK, Haller DG, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30(19):2327–33.

    Article  PubMed  CAS  Google Scholar 

  59. Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011; 29(33):4387–93.

    Article  PubMed  CAS  Google Scholar 

  60. Ott K, Fink U, Becker K, et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol. 2003;21(24):4604–10.

    Article  PubMed  CAS  Google Scholar 

  61. Ott K, Herrmann K, Krause BJ, Lordick F. The value of PET imaging in patients with localized gastroesophageal cancer. Gastrointest Cancer Res. 2008; 2(6):287–94.

    PubMed  PubMed Central  Google Scholar 

  62. Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241(2):247–55.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Mount Sinai Beth Israel Medical Center, New York, NY, USA

    Elizabeth P. Ketner M.D. & Martin S. Karpeh Jr. M.D.

  2. Department of Surgery, LSU Health Sciences Center-Shreveport, Shreveport, LA, USA

    Quyen D. Chu M.D., M.B.A., F.A.C.S.

  3. Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, USA, 14263

    Nikhil I. Khushalani M.D.

Authors
  1. Elizabeth P. Ketner M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Quyen D. Chu M.D., M.B.A., F.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin S. Karpeh Jr. M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nikhil I. Khushalani M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nikhil I. Khushalani M.D. .

Editor information

Editors and Affiliations

  1. Department of Surgery, LSU Health Sciences Center-Shreveport, Shreveport, Louisiana, USA

    Quyen D. Chu

  2. Department of Surgery, Jersey Shore University Medical Center, Neptune, New Jersey, USA

    John F. Gibbs

  3. John C. McDonald Regional Transplant Center, Willis Knighton Health System, Shreveport, Louisiana, USA

    Gazi B. Zibari

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ketner, E.P., Chu, Q.D., Karpeh, M.S., Khushalani, N.I. (2015). Gastric Cancer. In: Chu, Q., Gibbs, J., Zibari, G. (eds) Surgical Oncology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1423-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1423-4_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1422-7

  • Online ISBN: 978-1-4939-1423-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation